
Socioeconomic Factors in Uveal Melanoma Treatment ...
Jonathan Hwang’s Abstract Uveal melanoma (UM) is a rare but serious eye cancer. It has a high chance of metastatic spread, especially in advanced stages, which signif...
Learn more about our upcoming Galas and Signature Events Learn More
Guest blog post by Ian Michael Crumm, Celebrity Esthetician, Podcast Host, Key Opinion Leader, Melanoma Advocate and 2025 #GetNaked Spokesperson: Some moments stick with yo...
Jonathan Hwang’s Abstract Uveal melanoma (UM) is a rare but serious eye cancer. It has a high chance of metastatic spread, especially in advanced stages, which signif...
Haarisudhan Sureshkumar’s Abstract Uveal melanoma (UM) is the most common intraocular malignancy in adults and is known to have a poor prognosis. Although the genetic...
Sidharth Jain’s Abstract Melanocytes are a type of pigment-producing cell found in skin, hair, and eyes, but can form melanoma, a highly aggressive and deadly type of...
Amanda Zucker’s Abstract Uveal melanoma (UM) is a rare but lethal cancer of the eye. Despite initial successful treatment, 50% of patients experience spread of the ca...
Eric Kim’s Abstract Melanomas of the conjunctiva (CM) are very deadly. Knowledge regarding the social factors, especially insurance status such as Medicaid enrollment...
Michael Heiferman’s Abstract Uveal Melanoma (UM), a deadly cancer arising in the eye, is the most common eye cancer in adults. Early detection of UM is important due ...
Medical Student Award – Emily Gorden
Medical Student Award – Daniel Kim
Medical Student Award – Arina Nisanova
Uveal melanoma (UM) is the most common eye cancer in adults which originates from pigmented cells in the uvea of the eye. The major challenge in UM treatment is the high fr...
Uveal melanoma (UM) is a type of aggressive eye cancer that often spreads to the liver and has a poor prognosis. We don’t fully understand how UM spreads, which makes it ...
Description: Hybrid cells, in circulation and in the tumor are reprogrammed cancer cells displaying immune cell mimicry—insights into their impact on tumor progression, i...
Jul 22, 2025 ET